Chryseobacterium indologenes peritonitis in peritoneal dialysis

BMJ Case Reports

Volumn , Issue , 2013, Pages

  Afshar, Mehdi ^a   Nobakht, Ehsan ^a   Lew, Susie Q ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; ERTAPENEM; FLUCONAZOLE; GENTAMICIN; IMIPENEM; MORPHINE; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TOBRAMYCIN; VANCOMYCIN;

ABDOMINAL PAIN; ADULT; AFRICAN AMERICAN; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; CHRYSEOBACTERIUM INDOLOGENES; FOLLOW UP; HUMAN; KIDNEY FAILURE; LOOSE FECES; MALE; NAUSEA; PAIN; PERITONEAL DIALYSIS; PERITONEAL FLUID LEVEL; PERITONITIS; PRIORITY JOURNAL; TREATMENT OUTCOME; VOMITING;

EID: 84878983991     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2013-009410     Document Type: Article

References (24)

1. Levison ME, Bush LM. Chapter 71: Peritonitis and intra-abdominal abscesses. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 7th edn. Philadelphia, PA: Churchill Livingstone Press, 2009:1011-34.
2. Li PK, Szeto CC, Piraino B, et al. Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int 2010;30:393-423.
3. Woodrow G, Turney JH, Brownjohn AM. Technique failure in peritoneal dialysis and its impact on patient survival. Perit Dial Int 1997;17:360-4. (Pubitemid 27470211)
4. Perez-Fontan M, Rodriguez-Carmona A, Garcia-Naveiro R, et al. Peritonitis-related mortality in patients undergoing chronic peritoneal dialysis. Perit Dial Int 2005;25:274-84. (Pubitemid 40724208)
5. Murray PR, Pfaller MA, Tenover FC, et al. Manual of clinical microbiology. 6th edn. Washington, DC: ASM Press, 1995:528-30.
6. Steinberg JP, Burd EM. Chapter 237: Other Gram-negative and Gram-variable bacilli. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 7th edn. Philadelphia, PA: Churchill Livingstone Press, 2009:3015-33.
7. Shah S, Sarwar U, King EA, et al. Chryseobacterium indologenes subcutaneous port-related bacteremia in a liver transplant patient. Transpl Infect Dis 2012;14:398-402.
8. Lin JG, Wang WS, Yen CC, et al. Chryseobacterium indologenes bacteremia in a bone marrow transplant recipient with chronic graft-versus-host disease. Scand J Infect Dis 2003;35:882-3.
9. Christakis GB, Perlorentou SP, Chalkiopoulou I, et al. Chryseobacterium indologenes non-catheter-related bacteremia in a patient with a solid tumor. J Clin Microbiol 2005;43:2021-23.
10. Akay M, Gunduz E, Gulbas Z. Catheter-related bacteremia due to Chryseobacterium indologenes in a bone marrow transplant recipient. Bone Marrow Transplant 2006;37:435-6. (Pubitemid 43250480)
11. Nulens E, Bussels B, Bols A, et al. Recurrent bacteremia by Chryseobacterium indologenes in an oncology patient with a totally implanted intravenous device. J Clin Microbiol 2011;7:391-3.
12. Chen FL, Wang GC, Teng SO, et al. Clinical and epidemiological features of Chryseobacterium indologenes infections: analysis of 215 cases. J Microbiol Immunol Infect 2012. doi:10.1016/j.jmii.2012.08.007; e-pub 26 Sep 2012.
13. Hsueh PR, Teng LJ, Yang PC, et al. Increasing incidence of nosocomial Chryseobacterium indologenes infections in Taiwan. Eur J Clin Microbiol 1997;16:568-74. (Pubitemid 27417320)
14. Bonten MJ, Van Tiel FH, Van Der Geest S, et al. Topical antimicrobial prophylaxis of nosocomial pneumonia in mechanically ventilated patients: microbiological observations. J Infect 1993;21:137-9. (Pubitemid 23197138)
15. Stamm WE, Colella JJ, Anderson RL, et al. Indwelling arterial catheters as a source of nosocomial bacteremia: an outbreak caused by Flavobacterium species. N Engl J Med 1975;292:1099-102.
16. Kienzle N, Muller M, Pegg S. Chryseobacterium in burn wounds. Burns 2001;27:179-82. (Pubitemid 32156992)
17. Green BT, Nolan PE. Cellulitis and bacteremia due to Chryseobacterium indologenes. J Infect 2011;42:219-20.
18. Bhuyar G, Jain S, Shah H, et al. Urinary tract infection by Chryseobacterium indologenes. Indian J Med Microbiol 2012;30:370-2.
19. Lu PC, Chan JC. Flavobacterium indologenes keratitis. Ophthalmologica 1997;211:98-100. (Pubitemid 27102248)
20. Kirby JT, Sader HS, Walsh TR, et al. Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp.: report from the SENTRY Antimicrobial Surveillance Program (1997-2001). J Clin Microbiol 2004;42:445-8. (Pubitemid 38082768)
21. Maravic A, Skocibusic M, Samanic I, et al. Profile and multidrug resistance determinants of Chryseobacterium indologenes from seawater and marine fauna. World J Microbiol Biotechnol 2013;29:515-22.
22. Hsueh PR, Hsiue TR, Wu JJ, et al. Flavobacterium indologenes bacteremia: clinical and microbiological characteristics. Clin Infect Dis 1996;23:550-5.
23. Lin YT, Jeng YY, Lin ML, et al. Clinical and microbiological characteristics of Chryseobacterium indologenes bacteremia. J Microbiol Immunol Infect 2010;43:498-505.
24. Yoon JS, Hwang EA, Chang MH, et al. Peritonitis by Chryseobacterium indologenes and Sphingomonas paucimobilis in a patient undergoing continuous ambulatory peritoneal dialysis (CAPD). Korean J Nephrol 2007;26:801-5. Korean.